Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Huihe Medical

Request full access

Brings health and happiness to people with continuous innovation and excellent quality

ChinaFounded 2019Health Tech & Medtech

About Huihe Medical

Huihe Medical, formally Shanghai Huihe Medical Technology Co., Ltd., is a medical device company focused on developing interventional treatments for structural heart disease. Founded in May 2019 by Lin Lin, a former cardiologist, the company directs its efforts toward addressing unmet clinical needs in cardiac surgery. Lin's experience in cardiology, particularly in structural heart disease, informed the company's direction, leading to the pursuit of minimally invasive solutions for complex heart conditions like combined mitral and tricuspid valve disease.

The company operates in the cardiovascular intervention market, developing and producing medical devices for hospitals and cardiac surgeons. Its business model centers on the research, development, and eventual commercialization of its proprietary medical technologies. Huihe Medical generates revenue through the sale of these devices and has secured substantial funding to support its operations and growth. The company has successfully raised capital through multiple financing rounds, including an Angel round in 2019, a Series A round in 2020, and subsequent B and C rounds, attracting investment from firms like IDG Capital, Sherpa Capital, and Guotai Junan Innovation Investment.

Huihe Medical's flagship product is the K-Clip™, a transcatheter tricuspid annulus repair system designed to treat tricuspid regurgitation, a condition where the heart's tricuspid valve fails to close properly. This system is based on the Kay's surgical annuloplasty technique, adapted for a minimally invasive, transvascular approach that avoids open-heart surgery. The procedure has a reported average time of just 30 minutes, which presents a lower risk and faster recovery for patients, particularly the elderly. The K-Clip™ has completed humanitarian and confirmatory clinical trials in China and is undergoing studies for CE marking in Europe. Another key product is the S-wan, a dual-pole steerable sheath that recently received NMPA approval in China, making it the only domestically produced device of its kind.

Source: Dealroom company data

At a glance

Status
Operational
Employees
8
Open positions
None listed
Dealroom signal
40.7/100
Industry
Health
Sub-industry
Medical Devices
Sector
Surgery, Cardiology and cardiovascular, Chronic Disease, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DOther financing Dec 2025 $28M $1.1B China Taiping Insurance · Sherpa Venture Partners ↗
SERIES COther financing Dec 2022 $28M $110M Shanghai Kechuang Fund ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Huihe Medical website traffic

Latest recorded traffic for Huihe Medical is 890 monthly website visits, up 456.3% over the last three months. Huihe Medical's team declined 11.1% over the past year.

Latest monthly visits890 3-month web change+456.3% 1-year team growth-11.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Huihe Medical in its local ecosystem

Live from Dealroom

The Huihe Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later3 investors entered at this stage

  • Shanghai Kechuang Fund
  • China Taiping Insurance
  • Sherpa Venture Partners
Employees 8 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China66.7%
🇳🇱 Netherlands33.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Huihe Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Huihe Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.